In the latest trading session, Lemonade (LMND - Free Report) closed at $62.16, marking a -1.91% move from the previous day. This change lagged the S&P 500's 0.2% gain on the day.
Prior to today's trading, shares of the company had lost 5.43% over the past month. This has lagged the Finance sector's gain of 5.74% and the S&P 500's gain of 5.66% in that time.
Investors will be hoping for strength from LMND as it approaches its next earnings release, which is expected to be November 8, 2021. In that report, analysts expect LMND to post earnings of -$1.15 per share. This would mark a year-over-year decline of 101.75%. Meanwhile, our latest consensus estimate is calling for revenue of $33.63 million, up 88.95% from the prior-year quarter.
Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of -$3.77 per share and revenue of $124.17 million. These totals would mark changes of -3.86% and +31.53%, respectively, from last year.
It is also important to note the recent changes to analyst estimates for LMND. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. LMND is currently sporting a Zacks Rank of #4 (Sell).
The Insurance - Multi line industry is part of the Finance sector. This industry currently has a Zacks Industry Rank of 150, which puts it in the bottom 41% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
Zacks Naming Top 10 Stocks for 2024
Want to be tipped off early to our 10 top picks for the entirety of 2024?
History suggests their performance could be sensational.
From 2012 (when our Director of Research, Sheraz Mian assumed responsibility for the portfolio) through November, 2023, the Zacks Top 10 Stocks gained +974.1%, nearly TRIPLING the S&P 500’s +340.1%. Now Sheraz is combing through 4,400 companies to handpick the best 10 tickers to buy and hold in 2024. Don’t miss your chance to get in on these stocks when they’re released on January 2.
Be First to New Top 10 Stocks >>
In the latest trading session, Lemonade (LMND - Free Report) closed at $62.16, marking a -1.91% move from the previous day. This change lagged the S&P 500's 0.2% gain on the day.
Prior to today's trading, shares of the company had lost 5.43% over the past month. This has lagged the Finance sector's gain of 5.74% and the S&P 500's gain of 5.66% in that time.
Investors will be hoping for strength from LMND as it approaches its next earnings release, which is expected to be November 8, 2021. In that report, analysts expect LMND to post earnings of -$1.15 per share. This would mark a year-over-year decline of 101.75%. Meanwhile, our latest consensus estimate is calling for revenue of $33.63 million, up 88.95% from the prior-year quarter.
Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of -$3.77 per share and revenue of $124.17 million. These totals would mark changes of -3.86% and +31.53%, respectively, from last year.
It is also important to note the recent changes to analyst estimates for LMND. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. LMND is currently sporting a Zacks Rank of #4 (Sell).
The Insurance - Multi line industry is part of the Finance sector. This industry currently has a Zacks Industry Rank of 150, which puts it in the bottom 41% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
Zacks Naming Top 10 Stocks for 2024
Want to be tipped off early to our 10 top picks for the entirety of 2024?
History suggests their performance could be sensational.
From 2012 (when our Director of Research, Sheraz Mian assumed responsibility for the portfolio) through November, 2023, the Zacks Top 10 Stocks gained +974.1%, nearly TRIPLING the S&P 500’s +340.1%. Now Sheraz is combing through 4,400 companies to handpick the best 10 tickers to buy and hold in 2024. Don’t miss your chance to get in on these stocks when they’re released on January 2.
Be First to New Top 10 Stocks >>
Get the latest research report on LMND - FREE